M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Generex Biotechnology wins patents for vaccines targeting HPV induced cancers and influenza
Drug delivery company Generex Biotechnology (Other OTC:GNBT), based in Canada, reported on Wednesday the receipt of the US Patent Office's Notices of Allowance relating to applications for the use of therapeutic vaccines targeting cancers caused by human papilloma virus (HPV) as well as...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives